We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

In Blow To Teva, Federal Circuit Refuses To Rehear Zoloft Patent Case

Law360 (April 4, 2005, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has refused Israeli drug maker Teva Pharmaceuticals’ request for an en-banc rehearing of its patent case over a generic version of Pfizer Inc.'s antidepressant Zoloft.

In January, the Washington-based appeals court rejected Teva's bid to overturn a lower court ruling over whether the company could seek a court ruling that it did not infringe on Pfizer's brand-name patent before it released its generic version of Zoloft.

Teva had filed an Abbreviated New Drug Application (ANDA) with the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.